Visiogen Inc Funding Round - Series D 2009-05-01 | VC DATALAB

Deal date

1 May 2009

KANDO id: 696602

Financial Transaction:

Series D

Visiogen Inc

Currency

United States Dollar

Value in original currency

40,000,000

Value in USD

40,000,000

Round participants

Investor		Country	Notes
	CMEA Capital (CMEA Ventures) , (Chemical and Materials Enterprise Associates)	United States	Initial investment.
	Foundation Medical Partners	United States	Initial investment.
	New Leaf Venture Partners (NLV)	United States	Initial investment.
	Novartis Venture Funds The corporate venturing arm of Novartis.	Switzerland	Initial investment.
	Prospect Venture Partners Venture capital firm	United States	Initial investment.
	Technology Partners. Venture capital firm	United States	Initial investment.
	Three Arch Partners LP Venture capital firm focused on healthcare, medical devices, diagnostics, healthcare services, and biotechnology sectors.	United States	Initial investment.